Promise Details
Under Biden’s health and drug reform agenda, the Inflation Reduction Act introduced a cap on monthly insulin costs for Medicare beneficiaries (at $35) and also placed a hard limit on out-of-pocket drug expenditures (such as $2,000 annual cap). These moves were major components of his promise to make essential medicines more affordable. Supporters hailed them as landmark consumer protections. Some critics say the full benefits require fuller implementation, but these key reforms have been legally enacted and are active. Thus the promise is widely regarded as kept.
What was done
The Inflation Reduction Act codified a $35 monthly insulin cap for Medicare users and a $2,000 annual ceiling for out-of-pocket drug costs. These reforms are active and already benefiting millions of seniors. Health analysts highlight this as one of the administration’s most tangible cost-saving measures. Although private insurers are not yet fully covered, implementation of these provisions meets the central promise.
Sources
The information presented in this promise is aggregated from various publicly available sources. We do not claim ownership or guarantee the accuracy of the content. All data is collected and cross-validated from multiple independent sources. To read more about this promise, please view the source links below:
Support Our Work
Help us keep the website running and free for everyone by supporting us:
